Zeria Of Japan To Buy 85 Percent Of Danish Drug Maker Biofac
This article was originally published in PharmAsia News
Executive Summary
Japan's Zeria Pharmaceutical plans to acquire an 85 percent stake in Danish drug maker Biofac Esbjerg to expand the Japanese firm's reach in Europe